GO TO: Recent Comment Letters
ALL |
All 10-K/Qs
Large
Mid
Small
Micro
|
Earnings Release
Proxy
|
SORT BY :
Most Recent
Company Name
| Company | Time | Size | View | Financials | Document | SEC | Period | Revenue MRQ | Assets | EPS Diluted | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Korsana Biosciences, Inc. (CYCN) | 9/11/2026 4:30:17 PM | View | Financials | Earnings | SEC | 2Q 2026 | Assets $6,930,000 | EPS -$0.41 | Export Earnings Model | ||
| Cyclerion Therapeutics, Inc. (CYCN) | 8/4/2026 4:26:03 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2026 ending: 6/30/2026 | Assets $6,930,000 | EPS -$0.41 | ||
| Cyclerion Therapeutics, Inc. (CYCN) | 5/12/2026 4:22:02 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2026 ending: 3/31/2026 | Assets $8,505,000 | EPS -$0.76 | ||
| Cyclerion Therapeutics, Inc. (CYCN) | 4/30/2026 8:53:21 AM | Micro | View | Financials | 10-K/A | SEC | Y 2025 ending: 12/31/2025 | Rev: $2,074,000 +3.7% | Assets $9,985,000 | EPS -$1.11 | |
| Cyclerion Therapeutics, Inc. (CYCN) | 3/31/2026 6:13:43 AM | Micro | View | Financials | 10-K | SEC | Y 2025 ending: 12/31/2025 | Rev: $2,074,000 +3.7% | Assets $9,985,000 | EPS -$1.11 | |
| Cyclerion Therapeutics, Inc. (CYCN) | 11/12/2025 4:43:46 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2025 ending: 9/30/2025 | Rev: $875,000 +351.0% | Assets $10,415,000 | EPS -$0.30 | |
| Cyclerion Therapeutics, Inc. (CYCN) | 11/12/2025 4:22:40 PM | Micro | View | Financials | 10-K/A | SEC | Y 2024 ending: 12/31/2024 | Rev: $2,000,000 | Assets $9,575,000 | EPS -$1.21 | |
| Cyclerion Therapeutics, Inc. (CYCN) | 8/5/2025 4:42:22 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2025 ending: 6/30/2025 | Assets $9,370,000 | EPS -$0.11 | ||
| Cyclerion Therapeutics, Inc. (CYCN) | 5/6/2025 4:27:01 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2025 ending: 3/31/2025 | Rev: $81,000 | Assets $9,847,000 | EPS -$0.56 | |
| Cyclerion Therapeutics, Inc. (CYCN) | 4/29/2025 5:29:11 PM | View | Proxy | SEC | Y 2024 | ||||||
| Cyclerion Therapeutics, Inc. (CYCN) | 3/4/2025 4:24:23 PM | Micro | View | Financials | 10-K | SEC | Y 2024 ending: 12/31/2024 | Rev: $2,000,000 | Assets $9,575,000 | EPS -$1.21 | |
| Cyclerion Therapeutics, Inc. (CYCN) | 11/14/2024 4:41:07 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2024 ending: 9/30/2024 | Rev: $194,000 | Assets $8,898,000 | EPS -$0.29 | |
| Cyclerion Therapeutics, Inc. (CYCN) | 8/7/2024 6:57:24 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2024 ending: 6/30/2024 | Assets $10,065,000 | EPS -$0.53 | ||
| Cyclerion Therapeutics, Inc. (CYCN) | 5/7/2024 4:50:23 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2024 ending: 3/31/2024 | Assets $11,364,000 | EPS -$0.62 | ||
| Cyclerion Therapeutics, Inc. (CYCN) | 4/29/2024 4:29:24 PM | View | Proxy | SEC | Y 2023 | ||||||
| Cyclerion Therapeutics, Inc. (CYCN) | 3/5/2024 4:25:49 PM | Micro | View | Financials | 10-K | SEC | Y 2023 ending: 12/31/2023 | Assets $13,374,000 | EPS -$2.25 | ||
| Cyclerion Therapeutics, Inc. (CYCN) | 11/13/2023 4:47:51 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2023 ending: 9/30/2023 | Assets $15,214,000 | EPS $2.72 | ||
| Cyclerion Therapeutics, Inc. (CYCN) | 7/28/2023 4:57:25 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2023 ending: 6/30/2023 | Assets $10,097,000 | EPS -$1.83 | ||
| Cyclerion Therapeutics, Inc. (CYCN) | 6/20/2023 4:56:13 PM | View | Proxy | SEC | Y 2022 | ||||||
| Cyclerion Therapeutics, Inc. (CYCN) | 5/12/2023 6:10:49 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2023 ending: 3/31/2023 | Assets $11,456,000 | EPS -$3.20 | ||
| Cyclerion Therapeutics, Inc. (CYCN) | 4/3/2023 4:33:50 PM | View | Proxy | SEC | Y 2022 | ||||||
| Cyclerion Therapeutics, Inc. (CYCN) | 3/22/2023 5:07:55 PM | Micro | View | Financials | 10-K | SEC | Y 2022 ending: 12/31/2022 | Rev: $297,000 -92.5% | Assets $18,079,000 | EPS -$20.28 | |
| Cyclerion Therapeutics, Inc. (CYCN) | 3/22/2023 4:53:24 PM | View | Financials | Earnings | SEC | Y 2022 | Rev $0 | Assets $18,079,000 | EPS -$3.32 | Export Earnings Model | |
| Cyclerion Therapeutics, Inc. (CYCN) | 11/3/2022 5:17:47 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2022 ending: 9/30/2022 | Assets $25,053,000 | EPS -$4.83 | ||
| Cyclerion Therapeutics, Inc. (CYCN) | 8/11/2022 4:02:59 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2022 ending: 6/30/2022 | Rev: $306,000 -89.8% | Assets $35,213,000 | EPS -$6.16 | |
| Cyclerion Therapeutics, Inc. (CYCN) | 5/4/2022 4:20:42 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2022 ending: 3/31/2022 | Rev: $711,000 +1,046.8% | Assets $46,525,000 | EPS -$0.30 | |
| Cyclerion Therapeutics, Inc. (CYCN) | 5/4/2022 4:02:15 PM | View | Financials | Earnings | SEC | 1Q 2022 | Rev $711,000 +1,046.8% | Assets $46,525,000 | EPS -$0.30 | Export Earnings Model | |
| Cyclerion Therapeutics, Inc. (CYCN) | 4/26/2022 7:53:38 AM | View | Proxy | SEC | Y 2021 | ||||||
| Cyclerion Therapeutics, Inc. (CYCN) | 2/24/2022 4:18:00 PM | Micro | View | Financials | 10-K | SEC | Y 2021 ending: 12/31/2021 | Rev: $3,942,000 +71.7% | Assets $59,331,000 | EPS -$1.32 | |
| Cyclerion Therapeutics, Inc. (CYCN) | 11/9/2021 4:11:48 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2021 ending: 9/30/2021 | Rev: $348,000 -13.0% | Assets $67,742,000 | EPS -$0.26 | |
| Cyclerion Therapeutics, Inc. (CYCN) | 11/9/2021 4:03:43 PM | View | Financials | Earnings | SEC | 3Q 2021 | Rev $348,000 -13.0% | Assets $67,742,000 | EPS -$0.26 | Export Earnings Model | |
| Cyclerion Therapeutics, Inc. (CYCN) | 8/27/2021 5:43:54 PM | Micro | View | Financials | 10-K/A | SEC | Y 2020 ending: 12/31/2020 | Rev: $2,296,000 -49.1% | Assets $115,378,000 | EPS -$2.56 | |
| Cyclerion Therapeutics, Inc. (CYCN) | 8/27/2021 5:13:50 PM | Micro | View | Financials | 10-Q/A | SEC | 1Q 2021 ending: 3/31/2021 | Rev: $62,000 -93.9% | Assets $99,967,000 | EPS -$0.39 | |
| Cyclerion Therapeutics, Inc. (CYCN) | 8/27/2021 5:03:48 PM | Micro | View | Financials | 10-Q/A | SEC | 2Q 2021 ending: 6/30/2021 | Rev: $3,000,000 +300.5% | Assets $75,732,000 | EPS -$0.45 | |
| Cyclerion Therapeutics, Inc. (CYCN) | 7/29/2021 5:11:51 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2021 ending: 6/30/2021 | Rev: $3,000,000 +300.5% | Assets $75,732,000 | EPS -$0.45 | |
| Cyclerion Therapeutics, Inc. (CYCN) | 7/29/2021 4:56:30 PM | View | Financials | Earnings | SEC | 2Q 2021 | Rev $3,000,000 +300.5% | Assets $75,732,000 | EPS -$0.45 | Export Earnings Model | |
| Cyclerion Therapeutics, Inc. (CYCN) | 4/30/2021 4:15:11 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2021 ending: 3/31/2021 | Rev: $62,000 -93.9% | Assets $99,967,000 | EPS -$0.39 | |
| Cyclerion Therapeutics, Inc. (CYCN) | 4/28/2021 7:03:11 AM | View | Proxy | SEC | Y 2020 | ||||||
| Cyclerion Therapeutics, Inc. (CYCN) | 2/25/2021 7:44:26 AM | Micro | View | Financials | 10-K | SEC | Y 2020 ending: 12/31/2020 | Rev: $2,296,000 -49.1% | Assets $115,378,000 | EPS -$2.56 | |
| Cyclerion Therapeutics, Inc. (CYCN) | 2/25/2021 7:32:03 AM | View | Financials | Earnings | WIRE | Y 2020 | Rev $133,000 -91.0% | Assets $115,378,000 | EPS -$0.55 | Export Earnings Model | |
| Cyclerion Therapeutics, Inc. (CYCN) | 1/14/2021 12:15:27 PM | View | Presentation | SEC | 1Q 2021 | ||||||
| Cyclerion Therapeutics, Inc. (CYCN) | 11/5/2020 7:13:59 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2020 ending: 9/30/2020 | Rev: $400,000 -71.4% | Assets $131,402,000 | EPS -$0.59 | |
| Cyclerion Therapeutics, Inc. (CYCN) | 11/5/2020 7:01:53 AM | View | Financials | Earnings | WIRE | 3Q 2020 | Rev $400,000 -71.4% | Assets $131,402,000 | EPS -$0.59 | Export Earnings Model | |
| Cyclerion Therapeutics, Inc. (CYCN) | 8/3/2020 4:57:57 PM | View | Financials | Earnings | SEC | 2Q 2020 | Rev $749,000 -54.0% | Assets $128,038,000 | EPS -$0.70 | Export Earnings Model | |
| Cyclerion Therapeutics, Inc. (CYCN) | 8/3/2020 6:12:19 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2020 ending: 6/30/2020 | Rev: $749,000 -54.0% | Assets $128,038,000 | EPS -$0.70 | |
| Cyclerion Therapeutics, Inc. (CYCN) | 7/9/2020 4:44:21 PM | View | Presentation | SEC | Y 2020 | ||||||
| Cyclerion Therapeutics, Inc. (CYCN) | 5/4/2020 5:16:04 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2020 ending: 3/31/2020 | Rev: $1,014,000 | Assets $140,030,000 | EPS -$0.73 | |
| Cyclerion Therapeutics, Inc. (CYCN) | 4/23/2020 4:52:05 PM | View | Proxy | SEC | Y 2019 | ||||||
| Cyclerion Therapeutics, Inc. (CYCN) | 3/12/2020 5:01:25 PM | Small | View | Financials | 10-K | SEC | Y 2019 ending: 12/31/2019 | Rev: $4,507,000 | Assets $186,478,000 | EPS -$4.49 | |
| Cyclerion Therapeutics, Inc. (CYCN) | 11/12/2019 4:24:10 PM | Small | View | Financials | 10-Q | SEC | 3Q 2019 ending: 9/30/2019 | Rev: $1,398,000 | Assets $209,704,000 | EPS -$1.00 | |
| Cyclerion Therapeutics, Inc. (CYCN) | 10/30/2019 7:54:19 AM | View | Presentation | SEC | Y 2019 | ||||||
| Cyclerion Therapeutics, Inc. (CYCN) | 8/12/2019 5:26:56 PM | Small | View | Financials | 10-Q | SEC | 2Q 2019 ending: 6/30/2019 | Rev: $1,628,000 | Assets $235,503,000 | EPS -$1.18 | |
| Cyclerion Therapeutics, Inc. (CYCN) | 8/12/2019 8:09:10 AM | View | Financials | Earnings | SEC | 2Q 2019 | Rev $1,628,000 | Assets $235,503,000 | EPS -$1.18 | Export Earnings Model | |
| Cyclerion Therapeutics, Inc. (CYCN) | 5/13/2019 5:17:52 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2019 ending: 3/31/2019 | Assets $9,773,000 | EPS -$1.37 | ||
| Cyclerion Therapeutics, Inc. (CYCN) | 5/13/2019 7:04:13 AM | View | Earnings | SEC | 1Q 2019 | Assets $9,773,000 | EPS -$1.37 |